ABUS CIK: 1447028

Arbutus Biopharma Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.16
FY22:
0.15
FY23:
0.13
FY24:
0.13
FY25:
0.09
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.04
FY22:
0.04
FY23:
0.01
FY24:
0.00
FY25:
0.00
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.20
FY23:
0.14
FY24:
0.13
FY25:
0.09

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.03
FY23:
0.02
FY24:
0.02
FY25:
0.01
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.03
FY23:
0.02
FY24:
0.02
FY25:
0.01
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.17
FY22:
0.14
FY23:
0.11
FY24:
0.10
FY25:
0.08
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.20
FY23:
0.14
FY24:
0.13
FY25:
0.09

All amounts in billions USD Data sources:SEC EDGARTwelve Data